Drug Profile
Piroxantrone
Alternative Names: CI 942; NSC 349174; Oxantrazole; PD 111815Latest Information Update: 23 Jul 2002
Price :
$50
*
At a glance
- Originator Pfizer
- Class Anthraquinones; Cytostatics; Pyrazoles; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Breast cancer; Endometrial cancer; Gastric cancer; Malignant melanoma
Most Recent Events
- 12 Jul 2000 Profile reviewed but no significant changes made
- 22 Jun 2000 Warner-Lambert has merged with Pfizer
- 27 Aug 1998 Profile reviewed